Abstract
Purpose
To compare the advantages of prolotherapy in the treatment of first carpometacarpal osteoarthritis (OA) with those of corticosteroid local injection in the short and long term.
Methods
We performed a randomized controlled trial from March 2010 to March 2011 in an outpatient clinic at a university hospital. Sixty participants (60 hands) with OA of the first carpometacarpal joint were assigned equally to two groups. For the corticosteroid group, after 2 monthly saline placebo injections, a single dose of 40 mg methylprednisolone acetate (0.5 ml) mixed with 0.5 ml of 2 % lidocaine was injected. For the dextrose (DX) group, 0.5 ml of 20 % DX was mixed with 0.5 ml of 2 % lidocaine and the injection was repeated monthly for 3 months. Pain intensity, hand function and the strength of lateral pinch grip were measured at the baseline and at 1, 2, and 6 months after the treatment.
Results
Mean age (STD) was 63.6 (9.7) years, and mean (STD) visual analog scale (VAS) was 6 (2). The two groups were comparable at 2 months, but significantly different at 1 month, with better results for corticosteroid, and at 6 months with apparently more favorable outcome for DX [mean difference (95 % CI) in VAS = 1.1 (0.2, 2.0), p = 0.02]. After 6 months of treatment, both DX and corticosteroid injection increased functional level, but DX seemed to be more effective [mean difference (95 % CI) in total function score = 1.0 (0.2, 1.8), p = 0.01].
Discussion
For the long term, DX seems to be more advantageous, while the two treatments were comparable in the short term. Because of the satisfactory pain relief and restoring of function, we would prefer DX prolotherapy for the treatment of patients with OA.
Level of evidence
Therapeutic studies––investigating the results of treatment; level I.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
van Saase JLS, van Romunde LKR, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis. 1989;48:271–80.
Kloppenburg M. Hand osteoarthritis––an increasing need for treatment and rehabilitation. Curr Opin Rheumatol. 2007;19:179–83.
Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliubadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among elderly. Am J Epidemiol. 2002;156:1021–7.
Maheu E, Altman RD, Bloch DA, Doherty M, Hochberg M, Mannonia A, Punzi L, Specto T, Verbruggen G. Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. Osteoarthr Cartil. 2006;14:303–12.
Cusi M, Saunders J, Hungerford B, Wisbey-Roth T, Lucas P, Wilson S. The use of prolotherapy in the sacro-iliac joint. Br J Sports Med. 2010;44:100–4.
Joshi R. Intra-articular corticosteroid injection for first carpometacarpal osteoarthritis. J Rheumatol. 2005;32:1305–6.
Toker S, Kilinçoğlu V, Aksakalli E, Gülcan E, Ozkan K. Short-term results of treatment of tennis elbow with anti-inflammatory drugs alone or in combination with local injection of a corticosteroid and anesthetic mixture. Acta Orthop Traumatol Turc. 2008;42:184–7.
Dagenais S, Haldeman S, Wooley JR. Intraligamentous injection of sclerosing solution (prolotherapy) for spinal pain: a critical review of the literature. Spine J. 2005;5:310–28.
Dagenais S, Yelland MJ, DelMar C, Schoene ML. Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev. 2007;18:CD004059.
Rabago D, Best TM, Beamsley M, Pattersn J. A systematic review of prolotherapy for chronic musculoskeletal pain. Clin J Sport Med. 2005;15:376–80.
Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby RJ. Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res. 2008;26:816–23.
Schmidt H. Effect of growth factors on proliferation of fibroblasts from the medical collateral and anterior cruciate ligaments. J Orthop Res. 1995;13:184–90.
Schwartz R. Prolotherapy: a literature review and retrospective study. J Neurol Orthop Med Surg. 1991;12:220–3.
Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000;6:311–20.
Reeves K, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med. 2000;6:68–74.
Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med. 2003;9:58–62.
Dagenais S, Ogunseitan O, Haldeman S, Wooley JR, Newcomb RL. Side effects and adverse events related to intraligamentous injection of sclerosing solutions (prolotherapy) for back and neck pain: a survey of practitioners. Arch Phys Med Rehabil. 2006;87:909–13.
Ongley MJ, Klein RG, Dorman TA, Eek BC, Hubert LJ. A new approach to the treatment of chronic low back pain. Lancet. 1987;2:143–6.
Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18:248–54.
Watson JD, Shay BL. Treatment of chronic low-back pain: a 1-year or greater follow-up. J Altern Complement Med. 2010;16:951–8.
Yelland MJ, Sweeting KR, Lyftogt JA, Ng SK, Scuffham PA, Evans KA. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med. 2011;45:421–8.
Klein RG, Eek BC, DeLong WB, Mooney V. A randomized double-blind trial of dextrose-glycerine-phenol injections for chronic, low back pain. J Spinal Disord. 1993;6:23–33.
Kim WM, Lee HG, Jeong CW, Kim CM, Yoon MH. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med. 2010;16:1285–90.
Chou R, Atlas SJ, Stanos SP, Van zundert J, Vanelderen P, Kessels AG. Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline. Spine. 2009;34:1078–93.
Yelland MJ, Glasziou PP, Bogduk N, Kidd R. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine. 2004;29:9–16.
Dagenais S, Mayer J, Haldeman S, Borg-stein Y. Evidence-informed management of chronic low back pain with prolotherapy. Spine J. 2008;8:203–12.
Towheed TE. Systematic review of therapies for osteoarthritis of the hand. Osteoarthr Cartil. 2005;13:455–62.
Kjeken I, Dagfinrud H, Slatkowsky-Christensen B, Mowinckel P, Uhlig T, Kuien TK, Finset A. Activity limitations and participation restrictions in women and hand osteoarthritis: patients’ descriptions, and associations between dimensions of functioning. Ann Rheum Dis. 2005;64:1633–8.
Bruce B, Fries JF. The Stanford Health Assessment Questionnaire (HAQ): a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30:167–78.
Godwin M, Dawes M. Intra-articular steroid injections for painful knee: systematic review with meta-analysis. Can Fam Physician. 2004;50:241–8.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
This trial has been registered at the Iranian Registry of Clinical Trials (IRCT) website http://www.irct.ir/, a WHO Primary Register set-up, with registration code: Irct ID: IRCT201011025088N1.
About this article
Cite this article
Jahangiri, A., Moghaddam, F.R. & Najafi, S. Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. J Orthop Sci 19, 737–743 (2014). https://doi.org/10.1007/s00776-014-0587-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00776-014-0587-2